• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酶联免疫吸附测定法,用于检测针对人源和猪源大肠杆菌的纯化不耐热肠毒素以及霍乱毒素的抗体:在血清诊断和血清流行病学中的应用。

Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology.

作者信息

Levine M M, Young C R, Black R E, Takeda Y, Finkelstein R A

出版信息

J Clin Microbiol. 1985 Feb;21(2):174-9. doi: 10.1128/jcm.21.2.174-179.1985.

DOI:10.1128/jcm.21.2.174-179.1985
PMID:3882744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC271608/
Abstract

Serum immunoglobulin G antibodies to purified heat-labile enterotoxin (LT) from human (LTh) and porcine (LTp) Escherichia coli strains and cholera enterotoxin (CT) were measured by an enzyme-linked immunosorbent assay. Sera from patients with LTh E. coli infection showed a prominent response with LTh, an intermediate response with LTp, and a meager response with CT. Of 47 persons with clinical LTh-producing E. coli (herein shortened to LTh E. coli) infections, significant rises in antitoxin were detected against LTh in 36 (77%), against LTp in 30 (64%), and against CT in only 13 (28%) patients; seroconversions also occurred in 11 of 14 (79%) patients with subclinical LTh E. coli infections. In North Americans with experimental LTh E. coli infection, anti-Lth did not remain at high levels for more than 3 months. Persons with cholera manifested antitoxin responses that were similarly potent against all three toxin antigens; in fact, net optical density values were often slightly higher against LTh than against CT. The ratio of CT/LTh ELISA net optical density in convalescent sera proved to be a sensitive means to differentiate LT E. coli from cholera infection. All 11 cholera patients tested had CT/LTh ratios of greater than 0.70, whereas in only 1 of 47 LTh E. coli infections did the ratio exceed that value (it was 0.71) (P less than 0.0000000001). In single serum specimens, a net optical density of greater than or equal to 0.30 against LTh was shown to be a useful cutoff in screening sera for recent LTh E. coli or past cholera infection. The CT/LTh ratio was then used to differentiate definitively. Sera from healthy 3- to 5-year -olds and 15- to 19-year-olds in Maryland, Chile, and Bangladesh were tested against LTh and CT. The serological results fit known epidemiological observations. (i) LTh infections are rare in the United States (only 2 of 60 sera had LTh net optical density values of >/= 0.30. (ii) In contrast, evidence of recent LTh E. coli infections was very common in Chilean (69%) and Bangladeshi (57%) 3- to 5-year-olds and not uncommon in 15- to 19-year-olds (38 and 31%, respectively) in those countries. (iii) Only Bangladeshi sera showed serological evidence of cholera infections (CT/LTh ratios of > 0.70). The immunoglobulin G enzyme-linked immunosorbent assay measuring antibodies to purified LTh and CT represents a practical and effective tool for the serological study of LTh E. coli and cholera diarrheal infections.

摘要

采用酶联免疫吸附测定法检测人源(LTh)和猪源(LTp)大肠杆菌菌株的纯化不耐热肠毒素(LT)以及霍乱肠毒素(CT)的血清免疫球蛋白G抗体。LTh大肠杆菌感染患者的血清对LTh反应显著,对LTp反应中等,对CT反应微弱。在47例临床感染产LTh大肠杆菌(以下简称为LTh大肠杆菌)的患者中,36例(77%)检测到抗毒素针对LTh显著升高,30例(64%)针对LTp显著升高,仅13例(28%)患者针对CT显著升高;14例亚临床LTh大肠杆菌感染患者中有11例(79%)也发生了血清转化。在患有实验性LTh大肠杆菌感染的北美人群中,抗Lth水平在3个月以上未维持在高水平。霍乱患者表现出对所有三种毒素抗原同样有效的抗毒素反应;事实上,针对LTh的净光密度值往往比对CT的略高。恢复期血清中CT/LTh ELISA净光密度比值被证明是区分LT大肠杆菌感染和霍乱感染的敏感方法。所有11例接受检测的霍乱患者的CT/LTh比值均大于0.70,而在47例LTh大肠杆菌感染中只有1例(比值为0.71)该比值超过此值(P小于0.0000000001)。在单份血清标本中,针对LTh的净光密度大于或等于0.30被证明是筛查近期LTh大肠杆菌感染或既往霍乱感染血清的有用临界值。然后用CT/LTh比值进行明确鉴别。对马里兰州、智利和孟加拉国3至5岁及15至19岁健康人群的血清进行LTh和CT检测。血清学结果符合已知的流行病学观察结果。(i)在美国,LTh感染很少见(60份血清中只有2份LTh净光密度值≥0.30)。(ii)相比之下,在智利(69%)和孟加拉国(57%)3至5岁儿童中,近期LTh大肠杆菌感染的证据非常常见,在这些国家15至19岁人群中也并不少见(分别为38%和31%)。(iii)只有孟加拉国的血清显示有霍乱感染的血清学证据(CT/LTh比值>0.70)。测量针对纯化LTh和CT抗体的免疫球蛋白G酶联免疫吸附测定法是LTh大肠杆菌和霍乱腹泻感染血清学研究的实用有效工具。

相似文献

1
Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology.酶联免疫吸附测定法,用于检测针对人源和猪源大肠杆菌的纯化不耐热肠毒素以及霍乱毒素的抗体:在血清诊断和血清流行病学中的应用。
J Clin Microbiol. 1985 Feb;21(2):174-9. doi: 10.1128/jcm.21.2.174-179.1985.
2
Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin.抗大肠杆菌不耐热肠毒素的单克隆抗体:人源和猪源不耐热肠毒素及霍乱毒素的中和活性与鉴别
Med Biol. 1986;64(1):23-30.
3
Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.用霍乱毒素B亚单位和大肠杆菌不耐热毒素免疫的大鼠交叉保护作用的差异。
Infect Immun. 1984 Mar;43(3):811-6. doi: 10.1128/iai.43.3.811-816.1984.
4
Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli.霍乱弧菌感染与产肠毒素大肠杆菌感染所引发的抗毒素反应之间的血清学鉴别
J Infect Dis. 1983 Mar;147(3):514-22. doi: 10.1093/infdis/147.3.514.
5
Analysis of antigenic determinants in cholera enterotoxin and heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli.霍乱肠毒素及人源和猪源产肠毒素性大肠杆菌不耐热肠毒素中抗原决定簇的分析
Infect Immun. 1983 Jul;41(1):50-3. doi: 10.1128/iai.41.1.50-53.1983.
6
Characterization of monoclonal antibodies to heat-labile enterotoxin encoded by a plasmid from a clinical isolate of Escherichia coli.对来自大肠杆菌临床分离株的质粒编码的热不稳定肠毒素单克隆抗体的特性研究
Infect Immun. 1984 Mar;43(3):1027-32. doi: 10.1128/iai.43.3.1027-1032.1984.
7
Estimation of Vibrio cholerae and Escherichia coli heat-labile enterotoxin by enzyme-linked immunosorbent assay (ELISA).通过酶联免疫吸附测定法(ELISA)对霍乱弧菌和大肠杆菌不耐热肠毒素进行测定。
Acta Microbiol Acad Sci Hung. 1980;27(1):89-97.
8
Monoclonal antibodies with an expanded repertoire of specificities and potent neutralizing activity for Escherichia coli heat-labile enterotoxin.对大肠杆菌不耐热肠毒素具有特异性谱扩展和强大中和活性的单克隆抗体。
Infect Immun. 1984 Dec;46(3):759-64. doi: 10.1128/iai.46.3.759-764.1984.
9
Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb.霍乱毒素与大肠杆菌不耐热肠毒素LTh-I、LT-IIa和LT-IIb的碳水化合物结合特异性比较。
Infect Immun. 1988 Jul;56(7):1748-53. doi: 10.1128/iai.56.7.1748-1753.1988.
10
Molecular heterogeneity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli.来自人和猪产肠毒素大肠杆菌的不耐热肠毒素的分子异质性
Infect Immun. 1982 Nov;38(2):444-8. doi: 10.1128/iai.38.2.444-448.1982.

引用本文的文献

1
Seroprevalence of antibodies against Chlamydia trachomatis and enteropathogens and distance to the nearest water source among young children in the Amhara Region of Ethiopia.埃塞俄比亚阿姆哈拉地区幼儿中沙眼衣原体和肠道病原体抗体的血清流行率与最近水源的距离。
PLoS Negl Trop Dis. 2020 Sep 2;14(9):e0008647. doi: 10.1371/journal.pntd.0008647. eCollection 2020 Sep.
2
Enteropathogen antibody dynamics and force of infection among children in low-resource settings.资源匮乏环境下儿童肠道病原体抗体动态变化与感染强度。
Elife. 2019 Aug 19;8:e45594. doi: 10.7554/eLife.45594.
3
Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.秘鲁-15 pCTB单次口服递增剂量的安全性和免疫原性,秘鲁-15 pCTB是一种针对产肠毒素大肠杆菌和霍乱弧菌的减毒活疫苗候选物。
Clin Vaccine Immunol. 2015 Jan;22(1):129-35. doi: 10.1128/CVI.00560-14. Epub 2014 Nov 19.
4
Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models.使用基于微球的同步多重检测和有限混合模型开展热带传染病血清学监测
PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3040. doi: 10.1371/journal.pntd.0003040. eCollection 2014.
5
Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.由新的主细胞库和工作细胞库制备的单剂量口服霍乱活疫苗菌株CVD 103-HgR的安全性和免疫原性。
Clin Vaccine Immunol. 2014 Jan;21(1):66-73. doi: 10.1128/CVI.00601-13. Epub 2013 Oct 30.
6
Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine.单剂量减毒口服霍乱疫苗Peru-15安全性、免疫原性及保护效力的随机对照人体激发试验
Infect Immun. 2002 Apr;70(4):1965-70. doi: 10.1128/IAI.70.4.1965-1970.2002.
7
Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.表达产肠毒素大肠杆菌(ETEC)CS2和CS3菌毛的福氏志贺菌2a ΔguaBA减毒株CVD 1204作为预防志贺菌和ETEC感染的活黏膜疫苗。
Infect Immun. 2001 May;69(5):3150-8. doi: 10.1128/IAI.69.5.3150-3158.2001.
8
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.表达定居因子抗原I和产肠毒素大肠杆菌突变不耐热肠毒素的减毒福氏志贺菌2a疫苗株CVD 1204
Infect Immun. 2000 Sep;68(9):4884-92. doi: 10.1128/IAI.68.9.4884-4892.2000.
9
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.单剂量口服霍乱活疫苗CVD 103-HgR接种三个月后,用霍乱弧菌O1 El tor稻叶型毒株攻击,预防霍乱效果的随机、双盲、安慰剂对照、多中心试验。
Infect Immun. 1999 Dec;67(12):6341-5. doi: 10.1128/IAI.67.12.6341-6345.1999.
10
Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.口服侵袭性和非侵袭性减毒活细菌进行初次免疫和加强免疫后人体的黏膜和全身免疫反应
Infect Immun. 1999 Jul;67(7):3680-5. doi: 10.1128/IAI.67.7.3680-3685.1999.

本文引用的文献

1
Microtiter enzyme-linked immunosorbent assay for immunoglobulin g cholera antitoxin in humans: sensitivity and specificity.微量酶联免疫吸附试验检测人血清中霍乱免疫球蛋白 G 抗体:敏感性和特异性。
Infect Immun. 1980 Feb;27(2):497-500. doi: 10.1128/iai.27.2.497-500.1980.
2
Etiology of summer diarrhea among the Navajo.纳瓦霍人夏季腹泻的病因
Am J Trop Med Hyg. 1980 Jul;29(4):613-9. doi: 10.4269/ajtmh.1980.29.613.
3
In vitro formation of hybrid toxins between subunits of Escherichia coli heat-labile enterotoxin and those of cholera enterotoxin.大肠杆菌不耐热肠毒素亚基与霍乱肠毒素亚基之间杂合毒素的体外形成。
Infect Immun. 1981 Nov;34(2):341-6. doi: 10.1128/iai.34.2.341-346.1981.
4
Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology.北美人群感染霍乱弧菌后血清抗毒素反应的持续时间:对血清流行病学的意义
Am J Epidemiol. 1981 Sep;114(3):348-54. doi: 10.1093/oxfordjournals.aje.a113201.
5
Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique.人免疫球蛋白G霍乱抗毒素的微量滴定酶联免疫吸附测定:方法及与兔皮肤血管通透性因子技术的相关性
Infect Immun. 1980 Feb;27(2):492-6. doi: 10.1128/iai.27.2.492-496.1980.
6
Antibodies to heat-labile Escherichia coli enterotoxins in human milk and sera. A study of Ethiopian and Swedish mothers and their children.人乳和血清中针对不耐热大肠杆菌肠毒素的抗体。对埃塞俄比亚和瑞典母亲及其子女的一项研究。
Trop Geogr Med. 1981 Sep;33(3):225-30.
7
Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli.霍乱弧菌感染与产肠毒素大肠杆菌感染所引发的抗毒素反应之间的血清学鉴别
J Infect Dis. 1983 Mar;147(3):514-22. doi: 10.1093/infdis/147.3.514.
8
Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens.孟加拉国农村儿童传染病与身体发育的纵向研究。II. 腹泻发病率及其与已知病原体的关联。
Am J Epidemiol. 1982 Mar;115(3):315-24. doi: 10.1093/oxfordjournals.aje.a113308.
9
Immunological differences among the cholera/coli family of enterotoxins.霍乱/大肠杆菌肠毒素家族中的免疫学差异。
Diagn Microbiol Infect Dis. 1983 Jun;1(2):129-38. doi: 10.1016/0732-8893(83)90042-1.
10
Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin.霍乱毒素与大肠杆菌不耐热肠毒素之间的免疫学关系。
Infect Immun. 1983 Nov;42(2):683-91. doi: 10.1128/iai.42.2.683-691.1983.